We Cannot Win the Access to Medicines Struggle Using the Same Thinking That Causes the Chronic Access Crisis

Area of Science:

• Global Health
• Health Policy
• Pharmaceutical Economics

Background:

• The COVID-19 pandemic exposed significant global inequities in vaccine access.
• Historical challenges in accessing essential medicines, like during the AIDS crisis, persist.
• Current pharmaceutical economic models contribute to scarcity and rationing of health technologies.

Purpose of the Study:

• To analyze the root causes of health technology access inequities.
• To critically examine global health policies and institutional mechanisms for health access.
• To advocate for transformative change in the health innovation and access ecosystem.

Main Methods:

• Analysis of past trends in global health policies.
• Examination of the political economy underlying access problems.
• Critical review of existing access solutions and their inherent limitations.

Main Results:

• The rapid development of COVID-19 vaccines occurred alongside extreme access inequities.
• Existing solutions for health access can inadvertently perpetuate scarcity and inequity.
• The current pharmaceutical economy is ill-equipped to ensure equitable access to health technologies.

Conclusions:

• Addressing health access inequities requires understanding the political economy of health.
• Transformative changes are necessary in health innovation and access frameworks.
• Future solutions must prioritize equitable access to ensure the right to health.